Noticias

Compartir en Facebook Compartir en Twiter Compartir en Menéame Compartir en Linkedin Suscribirse a nuestra RSS

El CBD podría ser el nuevo agente antibacteriano

cule" title="" target="_blank">following study that corroborates it. Researchers report that they have achieved very promising results even with such aggressive bacteria as legionella, meningitis or gonorrhea that make millions of people sick, or even kill, worldwide.

Professor Mark Blaskovich of the University of Queensland found that "for the first time that cannabidiol can selectively kill a subset of gram-negative bacteria that includes the "urgent threat" pathogen Neisseria gonorrhoeae, this is the first time CBD has been shown kills some types of Gram negative bacteria. These bacteria have an additional outer membrane, an additional line of defense that makes it difficult for antibiotics to penetrate. "Also," We believe cannabidiol kills bacteria by bursting their outer cell membranes, but not yet we know exactly how it does it, and we need to do more research, "he said, explaining that CBD had a low incidence of creating resistance to bacteria.

This is especially important because conditions, such as gonorrhea, are generating resistance to common antibiotics. CBD was also found to break down the biofilm of bacteria that is the pathogen"s first line of defense in its resistance against drugs.

They used synthetic CBD for certain tests that allowed them to verify that, with small modifications in its structure, it increased its effectiveness in certain pathogens. "This is particularly exciting because new molecular classes of antibiotics for gram-negative infections have not been discovered and approved since the 1960s, and we can now consider designing new CBD analogs with improved properties," Blaskovich reported.

And it is that resistance to antibiotics is one of the biggest medical threats we face today. New forms of immune defense must be discovered to avoid resistance. We are in a new post-antibiotic historical stage and CBD seems to be running as a possible successor.